Oron-Herman M - Search Results

1

The effects of S-allylmercaptocaptopril, the synthetic product of allicin and captopril, on cardiovascular risk factors associated with the metabolic syndrome.

Oron-Herman M, Rosenthal T, Mirelman D, Miron T, Rabinkov A, Wilchek M, Sela BA. Oron-Herman M, et al. Atherosclerosis. 2005 Dec;183(2):238-43. doi: 10.1016/j.atherosclerosis.2005.03.009. Epub 2005 Apr 14. Atherosclerosis. 2005. PMID: 16285991

2

Hyperhomocysteinemia as a component of syndrome X.

Oron-Herman M, Rosenthal T, Sela BA. Oron-Herman M, et al. Metabolism. 2003 Nov;52(11):1491-5. doi: 10.1016/s0026-0495(03)00262-2. Metabolism. 2003. PMID: 14624412

3

The effects of allicin on weight in fructose-induced hyperinsulinemic, hyperlipidemic, hypertensive rats.

Elkayam A, Mirelman D, Peleg E, Wilchek M, Miron T, Rabinkov A, Oron-Herman M, Rosenthal T. Elkayam A, et al. Am J Hypertens. 2003 Dec;16(12):1053-6. doi: 10.1016/j.amjhyper.2003.07.011. Am J Hypertens. 2003. PMID: 14643581

4

Risk reduction therapy for syndrome X: comparison of several treatments.

Oron-Herman M, Sela BA, Rosenthal T. Oron-Herman M, et al. Am J Hypertens. 2005 Mar;18(3):372-8. doi: 10.1016/j.amjhyper.2004.10.012. Am J Hypertens. 2005. PMID: 15797656

5

Fructose-induced fatty liver disease: hepatic effects of blood pressure and plasma triglyceride reduction.

Ackerman Z, Oron-Herman M, Grozovski M, Rosenthal T, Pappo O, Link G, Sela BA. Ackerman Z, et al. Hypertension. 2005 May;45(5):1012-8. doi: 10.1161/01.HYP.0000164570.20420.67. Epub 2005 Apr 11. Hypertension. 2005. PMID: 15824194

6

Effects of amlodipine, captopril, and bezafibrate on oxidative milieu in rats with fatty liver.

Ackerman Z, Oron-Herman M, Rosenthal T, Pappo O, Link G, Sela BA, Grozovski M. Ackerman Z, et al. Dig Dis Sci. 2008 Mar;53(3):777-84. doi: 10.1007/s10620-007-9911-4. Epub 2007 Aug 22. Dig Dis Sci. 2008. PMID: 17710547

7

Effects of antihypertensive and triglyceride lowering agents on splenocyte apoptosis in rats with fatty liver.

Ackerman Z, Grozovski M, Oron-Herman M, Rosenthal T, Sela BA, Amir G. Ackerman Z, et al. Among authors: oron herman m. Basic Clin Pharmacol Toxicol. 2013 Jul;113(1):37-42. doi: 10.1111/bcpt.12067. Epub 2013 Apr 16. Basic Clin Pharmacol Toxicol. 2013. PMID: 23489555 Free article.

8

Effects of antihypertensive and triglyceride-lowering agents on hepatic copper concentrations in rats with fatty liver disease.

Ackerman Z, Skarzinski G, Grozovski M, Oron-Herman M, Sela BA. Ackerman Z, et al. Among authors: oron herman m. Basic Clin Pharmacol Toxicol. 2014 Dec;115(6):545-51. doi: 10.1111/bcpt.12283. Epub 2014 Aug 6. Basic Clin Pharmacol Toxicol. 2014. PMID: 24975050 Free article.

9

Effect of PPAR-gamma agonist on adiponectin levels in the metabolic syndrome: lessons from the high fructose fed rat model.

Sharabi Y, Oron-Herman M, Kamari Y, Avni I, Peleg E, Shabtay Z, Grossman E, Shamiss A. Sharabi Y, et al. Am J Hypertens. 2007 Feb;20(2):206-10. doi: 10.1016/j.amjhyper.2006.08.002. Am J Hypertens. 2007. PMID: 17261469

10

Metabolic syndrome: comparison of the two commonly used animal models.

Oron-Herman M, Kamari Y, Grossman E, Yeger G, Peleg E, Shabtay Z, Shamiss A, Sharabi Y. Oron-Herman M, et al. Am J Hypertens. 2008 Sep;21(9):1018-22. doi: 10.1038/ajh.2008.218. Epub 2008 Jun 19. Am J Hypertens. 2008. PMID: 18566592

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

20 results

Search Page

Filters